Addimag 160 mg/ml + 84 mg/ml solution for infusion for cattle
Addimag 160 mg/ml + 84 mg/ml solution for infusion for cattle
Authorised
- Calcium gluconate monohydrate
- Magnesium chloride hexahydrate
Product identification
Medicine name:
Addimag 160 mg/ml + 84 mg/ml Solution pour perfusion
Addimag 160 mg/ml + 84 mg/ml Oplossing voor infusie
Addimag 160 mg/ml + 84 mg/ml Infusionslösung
Addimag 160 mg/ml + 84 mg/ml solution for infusion for cattle
Active substance:
- Calcium gluconate monohydrate
- Magnesium chloride hexahydrate
Target species:
-
Cattle
Route of administration:
-
Solution for infusion
Product details
Active substance and strength:
-
Calcium gluconate monohydrate160.00milligram(s)1.00Piece
-
Magnesium chloride hexahydrate84.00milligram(s)1.00Piece
Pharmaceutical form:
-
Concentrate for solution for infusion
Withdrawal period by route of administration:
-
Solution for infusion
- Cattle
-
Meat and offalno withdrawal period
-
Milkno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA12AX
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- 500 ml square shaped clear polypropylene (PP) bottle with a bromobutyl rubber stopper and an aluminium screw cap
- 750 ml square shaped clear polypropylene (PP) bottle with a bromobutyl rubber stopper and an aluminium screw cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan Nederland B.V.
- Bela-Pharm GmbH & Co. KG
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V660951
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0352/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 11/04/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: